Vitamin D Deficiency as a Risk Factor for Thyroid Cancer: A Meta-analysis of Case-control studies 2018
Nutrition, online 2 June 2018, https://doi.org/10.1016/j.nut.2018.04.015
- Thyroid Cancer rate has increased 3X in 3 decades, Vitamin D Receptor decreases, Calcium increases – Aug 2017
- 2X more Thyroid Cancer malignancy if less than 15 ng of vitamin D – June 2012
Cancer category starts with the following
- Cancer
209 items Overview Cancer and vitamin D - After Cancer Diagnosis
84 items - Bladder Cancer
23 items - Breast Cancer
221 items Overview Breast Cancer and Vitamin D - Colon Cancer
113 items Overview Cancer-Colon and vitamin D - Leukemia
16 items - Liver Cancer
12 items - Lung Cancer
48 items Overview Lung cancer and vitamin D - Lymphoma Cancer
22 items - Other Cancer
55 items - Ovarian Cancer
21 items - Pancreatic Cancer
54 items - Prostate Cancer
91 items Prostate Cancer and Vitamin D studies - Skin Cancer
109 items Overview Suntans melanoma and vitamin D - Cancer incidence and mortality is decreased if 40-60 ng of Vitamin D – April 2019
- Vitamin D Reduces Cancer Risk - Why Scientists Accept It but Physicians Do Not - Feb 2019
- Vitamin D prevents breast cancer, reduces BC mortality, and reduces BC chemotherapy problems – Sept 2018
- Breast Cancer Mortality reduced 60 percent if more than 60 ng of Vitamin D – meta-analysis June 2017
- Diagnosed with breast cancer – take vitamin D to cut chance of death by half – July 2018
- Pancreatic cancer 55 percent less likely if optimal vitamin D (vs low) – Nov 2017
- Melanoma 25 X more likely if low vitamin D – Feb 2018
- Better Cancer survival if higher vitamin D a decade earlier (esp. Melanoma, Kidney, Prostate)– Aug 2018
Cancers get less Vitamin D when there is a poor Vitamin D Receptor
- Cancer and the Vitamin D Receptor, a primer – Sept 2017
- Cancer is leading cause of death - Vitamin D and Receptor activators help
- Risk of Cancer increased if poor Vitamin D Receptor – meta-analysis of 73 studies Jan 2016
- Cancer (general) and VDR
15 articles - Breast Cancer and VDR
15 articles - Colon Cancer and VDR
9 articles - Prostate Cancer and VDR
6 articles - Skin Cancer and VDR
9 articles - Note some Health problems, such as some Cancers, protect themselves by actively reducing Receptor activation
PDF is available free at Sci-Hub
Junyu Zhao, PhDa, 1, Haipeng Wang, PhDb, 1, Zhongwen Zhang, PhDa, Xiaojun Zhou, PhDa, Jinming Yao, M.D.a, Rui Zhang, PhDa, Lin Liao, PhDa, , , Jianjun Dong, PhDc, ,
Highlights
• The association between vitamin D deficiency and thyroid cancer is controversial
• The levels of serum 25-hydroxyvitamin D were lower in patients with thyroid cancer preoperative than those of controls
• There is no difference when thyroid cancer patients underwent a thyroidectomy
• Vitamin D deficiency may as a risk factor for thyroid cancerObjective
The association between vitamin D deficiency and thyroid cancer is controversial. Some reported that higher serum vitamin D level might protect against thyroid cancer. Whereas others did not show the same result, even propose the opposite opinion. To conclude the controversy above, we conducted this meta-analysis of association between vitamin D deficiency and thyroid cancer.Research Methods & Procedures
Database including PubMed, Cochrane library, Sinomed, CNKI, Wanfang, and clinical trial register centers, for case-control studies of vitamin D in thyroid cancer were searched. Fourteen articles were involved to conduct the meta-analysis.Results
There were 14 studies included in this meta-analysis. Fixed-effect model was used to merge the standardized mean difference value of serum 25-hydroxyvitamin D level and the pooled effect showed that the levels of serum 25-hydroxyvitamin D were lower in patients with thyroid cancer preoperative than those of controls (-0.22, 95% CI -0.36 to -0.09, P=0.001). But there is no difference when thyroid cancer patients underwent a thyroidectomy (-0.19, 95% CI -0.47 to 0.10, P=0.21). Fixed-effect model was used to pooled the odds ratio of thyroid cancer and vitamin D deficiency and it showed that the pooled odds ratio from six studies was 1.30 (95% CI 1.00 to 1.69, P=0.05). Subgroup analysis of 25-hydroxyvitamin D level between different pathological characteristics in patient with thyroid cancer was summarized, but no statistical difference was concluded.Conclusions
Lower serum 25-hydroxyvitamin D levels were associated with increased risk of thyroid cancer. Meanwhile, vitamin D deficiency may as a risk factor for thyroid cancer.
Thyroid cancer 1.4 X more likely if low Vitamin D meta-analysis - Oct 2018
Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis.
J Endocrinol Invest. 2018 Oct;41(10):1199-1210. doi: 10.1007/s40618-018-0853-9. Epub 2018 Feb 20.
Hu MJ1, Zhang Q1, Liang L1, Wang SY2, Zheng XC2, Zhou MM1, Yang YW1, Zhong Q1, Huang F3.PURPOSE: Although vitamin D is reportedly associated with various cancers, the association between vitamin D and thyroid cancer is indefinite. We aimed to investigate whether this association applies to thyroid cancer (TC).
METHODS: A total of 276 Chinese Han people were recruited in a current matched case-control study. Multivariable conditional logistic regression was computed to estimate the association between plasma 25(OH)D and papillary thyroid cancer (PTC). In addition, we searched relevant studies in PubMed and Web of Science databases before December 2017 to conduct a meta-analysis.
RESULTS:
In our case-control study, plasma 25(OH)D concentration was inversely associated with PTC risk (highest tertile vs lowest tertile: adjusted OR = 0.25; 95% CI 0.10, 0.61; Ptrend = 0.003). This association was independent of body mass index and physical activity (all adjusted Pinteraction > 0.05). A total of 11 studies were included in the meta-analysis, among which ten studies have been published and one was our case-control study. Compared with 25(OH)D non-deficient group, the pooled OR of TC was 1.42 (95% CI 1.17, 1.73) in the deficient group. Similarly, blood 25(OH)D levels in patients with TC were tend to be lower than those in the controls (SMD = - 0.20, 95% CI - 0.36, - 0.03).CONCLUSIONS: A high level of circulating 25(OH)D was associated with a decreased TC risk. This association has important significance in public health and should, therefore, be further studied.
See in VitaminDWiki at Thyroid Cancer 1.4 X higher risk if low vitamin D– meta-analysis Feb 2018
Thyroid Cancer 1.3X higher risk if low vitamin D (yet again) – meta-analysis June 2018Printer Friendly PDF this page! Follow this page for updates723 visitors, last modified 10 Jan, 2019, - Breast Cancer and VDR
- After Cancer Diagnosis